-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Zenas BioPharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2023 to Q2 2025.
- Zenas BioPharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$55.2M, a 38.9% decline year-over-year.
- Zenas BioPharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$189M.
- Zenas BioPharma, Inc. annual Operating Income (Loss) for 2024 was -$164M, a 341% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)